These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4090115)

  • 1. [Treatment of prostatic cancer patients].
    Serniak PS; Vinentsov IuA; Geev IuV
    Urol Nefrol (Mosk); 1985; (6):33-7. PubMed ID: 4090115
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is safe in the therapy of advanced prostatic cancer?].
    Gropp C; Burk K
    Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advancements in the treatment of prostate cancer.
    Dawkins CA; Crawford ED
    J Miss State Med Assoc; 1985 Sep; 26(9):245-50. PubMed ID: 4046018
    [No Abstract]   [Full Text] [Related]  

  • 4. Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate).
    Haapiainen R; Rannikko S; Ruutu M; Ala-Opas M; Aro J; Ervasti J; Hansson E; Hurme K; Juusela H; Mäkinen J
    Ann Chir Gynaecol; 1985; 74(6):277-83. PubMed ID: 4096480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the prostate in the elderly.
    Keegan GT; Coffield KS; Singh EO; Kroening PM
    Clin Geriatr Med; 1985 May; 1(2):359-71. PubMed ID: 3830370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment and prognosis of prostate carcinoma. Actual standing (author's transl)].
    Heising J; Allhoff E
    Z Hautkr; 1981 Jun; 56(11):705-14. PubMed ID: 6167082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orchiectomy, estrogen therapy and radiotherapy in locally advanced (T3-4 M0) prostatic cancer.
    Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
    Scand J Urol Nephrol Suppl; 1988; 110():103-7. PubMed ID: 3187397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of prostatic carcinoma.
    Bahnson RR; Catalona WJ
    Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid hormones in metastasizing prostate cancer treated with polyestradiol phosphate].
    Dunzendorfer U; Schulz H
    Z Urol Nephrol; 1982 Jul; 75(7):493-500. PubMed ID: 6183845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.
    Stege R; Grande M; Carlström K; Tribukait B; Pousette A
    Clin Cancer Res; 2000 Jan; 6(1):160-5. PubMed ID: 10656445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do radiotherapy and immediate orchiectomy yield comparable results as radical prostatectomy, adjuvant irradiation and orchiectomy in patients with stage D1 of prostatic carcinoma?].
    Wiegel T
    Strahlenther Onkol; 1995 Aug; 171(8):480-1. PubMed ID: 7652675
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphological factors in the prognosis of the treatment results in prostatic cancer].
    Murzaliev AD; Iiazaliev KT; Abdyldaev RA; Sizikov AI
    Urol Nefrol (Mosk); 1996; (1):22-5. PubMed ID: 8659037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium.
    Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J
    Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renaissance of estrogen therapy in advanced prostate carcinoma?].
    Smith PH; Robinson MR
    Urologe A; 1995 Sep; 34(5):393-7. PubMed ID: 7483156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testicular changes during estrogen therapy of prostatic cancer].
    Mihalache G; Adomnicăi G; Adomnicăi M; Iancu I; Mihalache C
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(2):343-5. PubMed ID: 3764207
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostatic cancer--what to do?].
    Bandhauer K
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1268-72. PubMed ID: 6635626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of gamma teletherapy of prostate cancer patients].
    Sviridova TV; Dunchik VN; Mardynskiĭ IuS; Tsodikova LB
    Med Radiol (Mosk); 1983 Nov; 28(11):15-20. PubMed ID: 6645824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostatic cancer].
    Soulié M; Barré C; Beuzeboc P; Chautard D; Cornud F; Eschwege P; Fontaine E; Molinié V; Moreau JL; Péneau M; Ravery V; Rébillard X; Richaud P; Ruffion A; Salomon L; Staerman F; Villers A;
    Prog Urol; 2004 Nov; 14(4 Suppl 1):913, 915-55. PubMed ID: 15779654
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.